AngioDynamics | ANGO - Operating Profit


AngioDynamics reported $-2.51M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 9.66M 9.14M Jun/2026
Boston Scientific USD 1.24B 190M Jun/2026
Edwards Lifesciences USD 519.5M 4.8M Jun/2026
ICU Medical USD 60.43M 30.05M Jun/2026
Inogen USD -7.79M 728K Sep/2024
J&J USD 7.48B 860M Jun/2026
Medtronic USD 2.09B 354M Mar/2026
Merit Medical Systems USD 60.4M 16.25M Jun/2026
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD 6.12M 1.91M Dec/2025
Smiths GBP 166M 76M Jun/2026
Tandem Diabetes Care USD -13.79M 3.64M Jun/2026
Teleflex USD 73.07M 36.04M Jun/2026
Terumo JPY 89.48B 58.03B Jun/2026
Trinity Biotech USD -1.3M 796K Dec/2025